• Thymosin-β4 Drives Angiogenesis in CLI via Notch/NF-κB Pathw

  2026-04-27

  This study demonstrates that thymosin-β4 (Tβ4) enhances angiogenesis and cell viability in a mouse model of critical limb ischemia (CLI) through the coordinated activation of Notch and NF-κB signaling. The findings illuminate a mechanistic pathway for therapeutic neovascularization in CLI, supported by robust in vitro and in vivo evidence.

• YC-1 in Translational Cancer Research: Beyond HIF-1α Inhibit

  2026-04-27

  Explore how YC-1 (5-(1-benzyl-1H-indazol-3-yl)furan-2-yl)methanol advances cancer research beyond conventional HIF-1α inhibition. This article reveals new mechanistic and translational insights, uniquely linking tumor hypoxia, angiogenesis, and neuroinflammatory pathways.

• Substance P (B6620): Protocol Guidance for CNS Research

  2026-04-26

  Substance P (SKU B6620) addresses the need for reliable tachykinin neuropeptide standards in studies on pain transmission, neuroinflammation, and immune response modulation. Its defined physicochemical properties and high purity enable reproducible CNS signaling assays, but use is strictly limited to research workflows and not suitable for diagnostic or clinical applications.

• CENPI Drives Breast Cancer Progression via Wnt/β-Catenin Pat

  2026-04-25

  Wu et al. (2025) identify centromere protein I (CENPI) as a key oncogenic driver in breast cancer, linking its overexpression to tumor progression and poor prognosis through modulation of the Wnt/β-catenin pathway. Their integrated approach, combining clinical data, cellular and animal models, and mechanistic assays, provides strong evidence positioning CENPI as a potential biomarker and therapeutic target.

• H 89 2HCl: Precision cAMP/PKA Pathway Inhibition in Cell Ass

  2026-04-24

  H 89 2HCl delivers unmatched selectivity for dissecting cAMP/PKA signaling, offering researchers a robust tool for modulating protein phosphorylation and cell differentiation. This guide details experimental workflows, troubleshooting tactics, and the latest insights from dopamine-regulated bone remodeling studies.

• Shufeng Xingbi Therapy: Modulating Th1/Th2 Balance and Gut F

  2026-04-24

  This study investigates how Shufeng Xingbi Therapy (SFXBT) affects Th1/Th2 immune balance and intestinal microbiota in an ovalbumin-induced allergic rhinitis rat model. Findings demonstrate that SFXBT alleviates nasal mucosal inflammation, shifts gut microbial composition, and downregulates key cytokines and transcription factors, offering mechanistic insight into its anti-allergic effects.

• Q-VD(OMe)-OPh: Advanced Caspase Inhibition for Apoptosis Ass

  2026-04-23

  Q-VD(OMe)-OPh stands out as a high-potency, low-cytotoxicity pan-caspase inhibitor, streamlining apoptosis research from cancer cell models to neuroprotection. Its workflow flexibility and robust performance, as illustrated in recent studies, empower researchers to precisely dissect cell death pathways and troubleshoot complex experimental setups.

• VX-765: Precision Caspase-1 Inhibition for Inflammation Mode

  2026-04-23

  VX-765 delivers unmatched selectivity for caspase-1, enabling rigorous dissection of IL-1β and IL-18-driven inflammation and pyroptosis. This article details advanced workflows, troubleshooting strategies, and translational insights empowered by VX-765, with a focus on blood-brain barrier repair and autoimmune research.

• Nitrocefin in Action: Unraveling β-Lactamase Diversity and R

  2026-04-22

  Explore Nitrocefin as a chromogenic cephalosporin substrate for advanced β-lactamase enzymatic activity measurement. This article delivers a deeper scientific lens on substrate specificity, cross-species resistance transfer, and modern assay optimization.

• Enhancing Detection Sensitivity: Cy3 TSA Fluorescence System

  2026-04-22

  The Cy3 TSA Fluorescence System Kit empowers researchers to detect low-abundance biomolecules with unmatched sensitivity and reproducibility. Leveraging HRP-driven tyramide signal amplification and robust Cy3 fluorescence, this kit transforms immunohistochemistry and in situ hybridization workflows for advanced biomarker discovery and validation.

• 5-Azacytidine in Epigenetic Research: Protocols and Innovati

  2026-04-21

  5-Azacytidine (5-AzaC) empowers precise DNA demethylation, enabling gene reactivation in cancer and epigenetics research. This article delivers stepwise protocols, real-world troubleshooting, and insights on leveraging APExBIO's validated 5-AzaC for reliable experimental outcomes.

• D-Lin-MC3-DMA: Ionizable Cationic Liposome for RNA Therapeut

  2026-04-21

  D-Lin-MC3-DMA is a benchmark ionizable cationic liposome enabling highly efficient mRNA and siRNA delivery in lipid nanoparticle (LNP) formulations. Its pH-sensitive properties maximize gene silencing efficacy while minimizing systemic toxicity, making it central to advances in hepatic and neuroinflammatory RNA therapeutics.

• Gepotidacin vs. Nitrofurantoin: Phase 3 UTI Trials and Resea

  2026-04-20

  The EAGLE-2 and EAGLE-3 phase 3 trials evaluated the efficacy and safety of oral gepotidacin compared to nitrofurantoin in treating uncomplicated urinary tract infections. Gepotidacin demonstrated non-inferiority and, in one trial, superiority, highlighting its potential as a novel oral antibiotic for resistant uropathogens.

• Cycloheximide: Precision Protein Biosynthesis Inhibitor in A

  2026-04-20

  Cycloheximide stands out as a gold-standard protein biosynthesis inhibitor, enabling acute, reversible suppression of protein synthesis for dissecting apoptosis, protein turnover, and viral immune evasion. This article details experimental workflows, troubleshooting strategies, and how recent research extends Cycloheximide's impact in advanced virology and cell death models.

• Brefeldin A: Applied Workflows for ER Stress and Cancer Cell

  2026-04-19

  Brefeldin A (BFA) is a gold-standard ER stress inducer and protein trafficking inhibitor, enabling precise interrogation of apoptosis pathways in cancer cell research. This guide delivers evidence-based workflows, troubleshooting strategies, and integrates the latest mechanistic insights for advanced cell biology applications.

16195 records 1/1080 page Next 12345 下5页 Last page